Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
read more
Wellgistics Health, Inc. announced that its wholly owned subsidiary, Wellgistics LLC, is collaborating with Protega Pharmaceuticals Inc. Protega is the specialty pharmaceutical company that launched ROXYBOND™ (oxycodone hydrochloride), the first and ...
read more
Wednesday, January 18, 2017
Protea Biosciences Group has announced that the company has signed a renewal of its collaboration with California-based Protein Metrics Inc. for further applications development of their advanced analytical software for Protea’s molecular information...
read more
Protea Biosciences announced it has integrated its therapeutic antibody analytical methods with new software developed by its partner, Protein Metrics.
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Protalix BioTherapeutics has entered into a non-binding term sheet with SarcoMed USA Inc.
read more
Tuesday, November 03, 2020
Protagonist Therapeutics announced two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech have been selected for advancement into clinical development.
read more
Protagen Protein Services GmbH and BioAnalytix announced a merger that will transform the combined company into a global analytic services provider for the biopharmaceutical industry.
read more
Wednesday, February 12, 2020
Protagen Protein Services (PPS) announced the appointment of Dr. Roland Moussa, as Chief Operating Officer.
read more
Protagen Protein Services (PPS) announced that it will merge with GeneWerk, an Ampersand portfolio company. With the addition of GeneWerk’s unique capabilities in vector safety, characterization, and functionality analysis, PPS will complement its ...
read more
Wednesday, December 14, 2016
PROTAGEN AG, a provider of pharma development services, companion diagnostics and novel diagnostic tests in the fields of immuno-oncology and autoimmune disease, has announced the launch of NavigAID SSc, a disease stratification assay designed to ...
read more
Tuesday, December 20, 2016
PROTAGEN AG, a provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today has announced the successful completion a collaboration agreement with Novartis ...
read more
ProSciento announced the appointment of Dr. Kelvin Logan, former President of Europe, Asia and Latin America at INC Research, to its Board of Directors.
read more
Wednesday, December 10, 2025
ProRx Pharma announced a major expansion of its operations with the addition of new clean rooms, automation, and robotic technologies.
read more
ProQR Therapeutics, a company dedicated to changing lives through transformative RNA therapies, announced new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical proof of concept data for its...
read more